The American Thyroid Association (ATA) integrates molecular testing into its framework for managing patients with anaplastic thyroid carcinoma (ATC): Update on the 2021 ATA ATC guidelines-Reference-Cited by-同舟云学术

The American Thyroid Association (ATA) integrates molecular testing into its framework for managing patients with anaplastic thyroid carcinoma (ATC): Update on the 2021 ATA ATC guidelines

Published:2021-10-07 Issue: Volume: Page:
ISSN:1934-662X
Container-title:Cancer Cytopathology
language:en
Short-container-title:Cancer Cytopathol

Author:

Silver Karcioglu Amanda¹^ORCID,Iwata Ayaka J.²,Pusztaszeri Marc³^ORCID,Abdelhamid Ahmed Amr H.¹^ORCID,Randolph Gregory W.¹⁴^ORCID

Affiliation:

1. Division of Thyroid and Parathyroid Endocrine Surgery, Department of Otolaryngology‐Head and Neck Surgery Massachusetts Eye and Ear Infirmary, Harvard Medical School Boston Massachusetts

2. Massachusetts Eye & Ear Infirmary Boston Massachusetts

3. Department of Pathology Jewish General HospitalMcGill University Montreal Quebec Canada

4. Department of Surgery Massachusetts General Hospital, Harvard Medical School Boston Massachusetts

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncy.22519

Reference31 articles.

1. 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer

2. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines

4. NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018

5. The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and recommendations for treatments of thyroid cancer

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anaplastic thyroid cancer: A review of recent evidence and summary of an Australian institutional protocol;Asia-Pacific Journal of Clinical Oncology;2024-08-15

2. The evolving role of interventional cytopathology from thyroid FNA to NGS: Lessons learned at Federico II University of Naples;Cytopathology;2024-07-09

3. Current status of anaplastic thyroid carcinoma;World Journal of Clinical Oncology;2024-06-24

4. Efficacy and safety of BRAF/MEK inhibitors in BRAFV600E-mutated anaplastic thyroid cancer: a systematic review and meta-analysis;Endocrine;2024-05-06

5. Nuklearmedizin bei anaplastischem Schilddrüsenkrebs;Nuklearmedizin bei endokrinen Erkrankungen;2024